Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jan. 29, 2022

Summary of Significant Accounting Policies

Reconciliation of cash and restricted cash equivalents [Table Text Block]

The following table provides a reconciliation of cash and restricted cash equivalents reported with the consolidated balance sheets to the total of the same amounts shown in the consolidated statements of cash flows:

	January 29, 2022		January 30, 2021		February 1, 2020
Cash	$	11,295	$	15,485	$	10,287
Restricted cash equivalents		1,893		—		—
Total cash and restricted cash equivalents	$	13,188	$	15,485	$	10,287

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

A reconciliation of net loss per share calculations and the number of shares used in the calculation of basic net loss per share and diluted net loss per share is as follows:

	For the Years Ended
	January 29, 2022		January 30, 2021		February 1, 2020
Numerator:
Net loss attributable to shareholders	$	(22,008)	$	(13,234)	$	(56,296)
Earnings allocated to participating share awards		—		—		—
Net loss attributable to common shares — Basic and diluted	$	(22,008)	$	(13,234)	$	(56,296)
Denominator:
Weighted average number of common shares outstanding — Basic (a)		19,362,062		10,745,916		7,462,380
Dilutive effect of stock options, non-vested shares and warrants (b)		—		—		—
Weighted average number of common shares outstanding — Diluted		19,362,062		10,745,916		7,462,380
Net loss per common share	$	(1.14)	$	(1.23)	$	(7.54)
Net loss per common share — assuming dilution	$	(1.14)	$	(1.23)	$	(7.54)

(a) During fiscal 2018, the Company issued a restricted stock award that is a participating security. For fiscal 2021, fiscal 2020 and fiscal 2019, the entire undistributed loss is allocated to common shareholders.

(b) For fiscal 2020, the basic earnings per share computation included 21,000 outstanding fully paid warrants to purchase shares of the Company’s common stock at a price of $0.001 per share.

(c) For fiscal 2021, fiscal 2020 and fiscal 2019, there were approximately 960,000, 591,000 and 46,000 incremental, in-the-money, potentially dilutive common shares outstanding. The incremental in-the-money potentially dilutive common stock shares are excluded from the computation of diluted earnings per share, as the effect of their inclusion would be anti-dilutive.